MCK

Prezzo Mckesson Corp

MCK
$835,00
+$6,68(+0,80%)

*Data last updated: 2026-04-28 20:38 (UTC+8)

As of 2026-04-28 20:38, Mckesson Corp (MCK) is priced at $835,00, with a total market cap of $101,45B, a P/E ratio of 26,02, and a dividend yield of 0,38%. Today, the stock price fluctuated between $829,42 and $841,84. The current price is 0,67% above the day's low and 0,81% below the day's high, with a trading volume of 907,46K. Over the past 52 weeks, MCK has traded between $817,44 to $887,25, and the current price is -5,88% away from the 52-week high.

MCK Key Stats

Yesterday's Close$828,11
Market Cap$101,45B
Volume907,46K
P/E Ratio26,02
Dividend Yield (TTM)0,38%
Dividend Amount$0,82
Diluted EPS (TTM)35,22
Net Income (FY)$3,29B
Revenue (FY)$359,05B
Earnings Date2026-05-07
EPS Estimate11,56
Revenue Estimate$101,28B
Shares Outstanding122,51M
Beta (1Y)0.423
Ex-Dividend Date2026-06-01
Dividend Payment Date2026-07-01

About MCK

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
SectorHealthcare
IndustryMedical - Distribution
CEOBrian S. Tyler
HeadquartersIrving,TX,US
Official Websitehttps://www.mckesson.com
Employees (FY)45,00K
Average Revenue (1Y)$7,97M
Net Income per Employee$73,22K

Mckesson Corp (MCK) FAQ

What's the stock price of Mckesson Corp (MCK) today?

x
Mckesson Corp (MCK) is currently trading at $835,00, with a 24h change of +0,80%. The 52-week trading range is $817,44–$887,25.

What are the 52-week high and low prices for Mckesson Corp (MCK)?

x

What is the price-to-earnings (P/E) ratio of Mckesson Corp (MCK)? What does it indicate?

x

What is the market cap of Mckesson Corp (MCK)?

x

What is the most recent quarterly earnings per share (EPS) for Mckesson Corp (MCK)?

x

Should you buy or sell Mckesson Corp (MCK) now?

x

What factors can affect the stock price of Mckesson Corp (MCK)?

x

How to buy Mckesson Corp (MCK) stock?

x

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.

Other Trading Markets

Hot Posts su Mckesson Corp (MCK)

0xInsomnia

0xInsomnia

2025-10-14 16:27
AmerisourceBergen (ABC) has emerged as an intriguing prospect for value investors, particularly when viewed through a Web3-enhanced lens. While traditional value investing focuses on identifying undervalued companies using conventional metrics, our analysis incorporates both classic financial indicators and forward-looking Web3 concepts to provide a more comprehensive evaluation. ## Traditional Value Metrics ABC currently boasts a Zacks Rank of #2 (Buy) and a Value grade of A, signaling strong potential for value investors. The stock's P/E ratio stands at 15.41, compared to its industry average of 19.01, suggesting relative undervaluation. ABC's Forward P/E has fluctuated between 11.77 and 15.57 over the past year, with a median of 13.60. Another key metric, the P/CF ratio, focuses on a firm's operating cash flow. ABC's P/CF ratio of 15.83 appears attractive against its industry average of 23.22. This ratio has ranged from 10.91 to 15.99 in the past year, with a median of 13.27. ## Web3 Integration Potential While AmerisourceBergen operates in the traditional pharmaceutical distribution sector, assessing its value from a Web3 perspective offers unique insights: 1. **Blockchain-Enhanced Supply Chain**: ABC's potential to integrate blockchain technology into its supply chain could significantly improve transparency, efficiency, and security. This Web3 application could translate to substantial cost savings and improved operational metrics. 2. **Tokenization of Assets**: The company's vast inventory and distribution network could be prime candidates for tokenization, potentially unlocking new value streams and improving liquidity management. 3. **Smart Contract Implementation**: Adopting smart contracts for vendor agreements and customer orders could streamline operations and reduce administrative overhead, positively impacting the company's financial ratios. ## Comparative Analysis: McKesson (MCK) To provide context, let's compare ABC with its industry peer, McKesson (MCK): | Metric | AmerisourceBergen (ABC) | McKesson (MCK) | Industry Average | |--------|-------------------------|-----------------|-------------------| | Zacks Rank | #2 (Buy) | #2 (Buy) | - | | Value Grade | A | A | - | | P/E Ratio | 15.41 | 14.85 | 19.01 | | Forward P/E Range (1 Year) | 11.77 - 15.57 | 12.75 - 15.66 | - | | P/CF Ratio | 15.83 | Not Available | 23.22 | | PEG Ratio | Not Available | 1.37 | 1.50 | MCK trades at a forward earnings multiple of 14.85 and a PEG ratio of 1.37, compared to the industry's P/E of 19.01 and PEG of 1.50. MCK's P/B ratio stands at -37.26, which is notably different from the industry average of 7.14. ## Web3 Value Proposition From a Web3 perspective, both ABC and MCK could benefit from: 1. **Decentralized Data Management**: Implementing decentralized systems for managing vast amounts of healthcare data could enhance security and interoperability. 2. **Token-Based Incentive Systems**: Developing token-based loyalty programs for pharmacies and healthcare providers could create new revenue streams and strengthen market positions. 3. **Blockchain-Verified Pharmaceuticals**: Utilizing blockchain to verify the authenticity of pharmaceuticals could add significant value to their distribution networks and potentially command premium pricing. By considering these Web3 factors alongside traditional value metrics, investors can gain a more holistic view of these companies' potential in an evolving digital landscape. The combination of strong traditional value indicators and promising Web3 integration potential suggests that AmerisourceBergen and McKesson may indeed be undervalued in the current market. As the healthcare industry continues to evolve with technological advancements, these companies' adaptability to Web3 technologies could become a crucial factor in their long-term value proposition.
0
0
0
0